The Swiss drugmaker said it would pay Nurix $700 million upfront, while development costs would be split 60-40, with Roche taking the larger share.
Source link
Roche Enters $2.3 Billion Blood-Cancer Drug Deal With Nurix Therapeutics
Date:
More like thisRelated
Major earthquake in southern Philippines kills at least 16, spawns yard-high tsunami
Manila, Philippines — - An...
Intesa Makes $35 Billion Bid for Monte dei Paschi to Rival BPM’s Merger Plan
The approaches pit Intesa and BPM against each other...